Zhou et al. found METTL3 was abnormally expressed in renal carcinoma, and its expression was higher than that of normal tissue [99], while Deng et al. showed METTL3 has a tumour suppressive effect in colorectal cancer [100]. Here, METTL3 is linked to neoplasm.